What's your take on what's happening right now at FDA as it relates to the medical, uh, devices industry, particularly what's happened over the last year, and how have things changed? How are things more challenging or less challenging for the industry? Mark, let me start with you on that.

Yeah, it's-- what a great and broad question.

Let me start off with just saying from a personnel and process standpoint, you know, uh, Michelle Tarver, Dr. Tarver, who's the center director, has really been a breath of fresh air.

She's really a great leader.

She's a compassionate leader.

She's very knowledgeable.

Um, and we just-- she just did a town hall here in Minneapolis with Medical Alley, and, uh, we had, you know, over 300 attendees, and she came with some of her colleagues, uh, as well, and they had a panel, and then they did breakout sessions.

Where are the breakdowns and what do you do about them?